Therapeutics: Phosphodiesterase-4 (PDE-4); fragile X mental retardation 1 (FMR1)

Neurology

INDICATION: Fragile X syndrome

Mouse and fly studies suggest that PDE-4 inhibitors could help treat cognitive impairment in patients with

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE